Related by context. All words. (Click for frequent words.) 70 FDA Anti Infective 70 Oncologic Drugs Advisory 69 FDA Oncologic Drugs 69 FDA Endocrinologic 68 Arthritis Advisory 67 PDUFA Date 67 FDA Dermatologic 66 Anti Infective Drugs 65 Ophthalmic Drugs Advisory 65 Drugs Advisory 65 Metabolic Drugs Advisory 64 Devices Advisory Panel 64 Pulmonary Allergy Drugs 63 AIDAC 62 FDA Pulmonary Allergy 62 ezogabine 61 PIX# [002] 61 FDA Approvable Letter 61 FDA Psychopharmacologic Drugs 61 Kiacta 61 Psychopharmacologic Drugs Advisory 61 Romiplostim 61 Endocrinologic 61 Pivotal Clinical Trial 61 Kynapid 61 Orexigen Contrave 61 CHMP recommendation 60 FDA Antiviral Drugs 60 approvability 60 Expanded Indication 60 Dendreon Provenge 60 Ocrelizumab 60 Xinlay 60 Febuxostat 60 STELARA TM 60 LibiGel ® 60 Complete Response 60 FDA 60 Accelerated Approval 59 Angiox ® 59 Antiviral Drugs Advisory 59 Auxilium Pharma 59 Pegloticase 59 rasagiline tablets 59 Golimumab 59 Arthritis Drugs 59 PDUFA Prescription Drug 59 Arthritis Drug 59 DSMB 59 Cethromycin 59 Resubmission 59 alvimopan 59 Muraglitazar 59 Telavancin 59 Bazedoxifene 59 Society CTOS 59 guanfacine extended release 59 Sanofi Acomplia 59 SPARLON 59 ONGLYZA ™ 59 Zarnestra 59 PMA Supplement 59 Vernakalant 59 Potiga 59 Pirfenidone 59 Metabolic Drugs 59 FDA Accepts 58 Tezampanel 58 Amyvid 58 Fablyn 58 Nabi HB Intravenous 58 Prostate Cancer Vaccine 58 Fondaparinux 58 FDA approvable letter 58 Ranolazine 58 approvable letters 58 Marketing Authorisation Application 58 Extina 58 Renal Drugs Advisory 58 Lilly Cymbalta 58 Aflibercept 58 QNEXA 58 liver resection surgeries 58 Clinical Trial Results 58 RhuDex 58 CONBRIZA 58 Vandetanib 58 Patient Enrollment 58 Civacir 58 Avastin bevacizumab 58 Clinical Trial Data 58 FDA Circulatory System 58 MAA submission 58 Augment ™ Bone Graft 58 Afinitor everolimus 58 Noxafil 58 Phase III Clinical Trials 57 Phase III Clinical Trial 57 Vivus Qnexa 57 Lorqess 57 Nebido 57 PROMACTA 57 Vertex hepatitis C 57 DORIBAX 57 Egrifta 57 Promacta 57 Endeavor Drug Eluting 57 Inhaled Insulin 57 Glufosfamide 57 Roche Actemra 57 First Patient Enrolled 57 Product Monograph 57 CHMP 57 Expedited Review 57 Zenpep 57 Phase III Trials 57 Pivotal Phase III 57 Completes Patient Enrollment 57 Gout Drug 57 Keryx Biopharma 57 Epilepsy Drug 57 Generic Lovenox 57 Late Breaker 57 Regeneron Pharma 57 TORISEL TM 57 BRILINTA 57 Nonprescription Drugs 57 Drug Administration Oncologic Drugs 57 NDA Submission 57 Alogliptin 57 Omalizumab 57 AstraZeneca Iressa 57 Azathioprine 57 Coadministration 57 Orphan Designation 57 Boceprevir 57 Taro Receives 57 Schizophrenia Drug 57 Investigational Compound 57 ASCO GI 57 Fast Track Status 56 MAGE A3 ASCI 56 Celgene Revlimid 56 ICAAC IDSA 56 Bifeprunox 56 Linjeta 56 Sanvar R 56 Risperidone Oral Solution 56 Cellegesic 56 Vertex telaprevir 56 Generic Versions 56 APPRAISE 56 TYZEKA 56 Dr. Gulfo 56 Advagraf 56 Nexavar sorafenib 56 Amgen Nplate 56 Phase 2a Trial 56 MyVax 56 FDA Approvals 56 AVANDIA 56 Marketing Authorization Applications 56 FASLODEX 56 Drug Fails 56 Doribax 56 Orphan Status 56 Faropenem 56 Novel Antibiotic 56 PROVENGE ® 56 DNAwithPap TM Test 56 Biologic License Application 56 muraglitazar 56 Pulminiq 56 Pixuvri 56 Mycamine 56 Biologics Licensing 56 Hedgehog Pathway Inhibitor 56 TOPAMAX R 56 IND Application 56 Citizen Petition 56 T Pred 56 dual endothelin receptor antagonist 56 Migraine Drug 56 Files Investigational 56 ARIXTRA R 56 Weight Loss Drug 56 Fabry Disease 56 Sanctura XR 56 Pivotal Trial 56 Final Appraisal Determination 56 AstraZeneca Symbicort 56 Osteoporosis Drug 56 TYKERB 56 Psoriasis Drug 56 Granted Orphan Drug 56 Firazyr 56 Celebrex celecoxib 56 ANDA Filing 56 PrandiMet 56 myelodysplastic myeloproliferative diseases 56 Hepatitis B Vaccine 56 Lupus Drug 56 Neurological Devices 56 Ariad Pharma 56 Potent Antiviral Activity 56 Hepatotoxicity 56 PDUFA date 56 Cholesterol Lowering Drug 56 Cladribine 56 Luveris 56 lucinactant 56 Tanespimycin 56 Velcade bortezomib 56 Ozurdex 56 User Fee Act 56 Initiates Clinical 56 AVERROES 56 Biogen NASDAQ BIIB 56 ACOMPLIA R 56 Archexin 56 Aviptadil 56 Vicriviroc 56 hylan GF 55 Onrigin 55 IND Filing 55 INVEGA ® 55 Positive Opinion 55 Certican 55 NOXAFIL 55 SANVAR 55 Efficacy Results 55 Arzerra ofatumumab 55 Rheumatoid Arthritis Drug 55 Anidulafungin 55 Zalbin 55 Nasdaq CYCC Nasdaq CYCCP 55 Torisel 55 PrevOnco 55 HCV Protease Inhibitor 55 CDRH 55 Bicifadine 55 Marketing Authorisation 55 abatacept Orencia 55 NASDAQ BDSI 55 ISTODAX 55 reslizumab 55 Successfully Completes Phase 55 Amlodipine Besylate 55 gadobutrol 55 AstraZeneca Brilinta 55 Receives Approvable Letter 55 CERVARIX R 55 Dasatinib 55 XIAFLEX TM 55 Anemia Drug 55 ARCOXIA 55 RSR# 55 Optimer Pharma 55 ganetespib 55 Prestara 55 Androxal ® 55 FOLOTYN ® 55 Submits NDA 55 Hormone Refractory Prostate Cancer 55 Glaxo Rotarix 55 Long Term Efficacy 55 brivaracetam 55 Prostate AdenoCarcinoma Treatment 55 BLA filing 55 Gilenia 55 Vimpat R 55 Vyvanse lisdexamfetamine dimesylate 55 Bayer Onyx 55 Belimumab 55 Not Approvable 55 Lung Cancer Drug 55 Proxy Proposals 55 Amgen Prolia 55 FDA Complete Response 55 Generic Version 55 Vidaza azacitidine 55 R lenalidomide 55 Raptiva ® 55 See CLINICAL PHARMACOLOGY 55 Vilazodone 55 Omapro 55 Tasigna nilotinib 55 OMP designation 55 desvenlafaxine 55 RECOTHROM R 55 balsalazide tablet 55 OSI Pharma 55 SUTENT ® 55 Statin Drugs 55 Biologic License Application BLA 55 Raptiva R 55 Halozyme Therapeutics 55 MEDCAC 55 Trobalt 55 NASDAQ VRTX 55 Pre IND 55 Drug Administration FDA Oncologic 55 Carfilzomib 55 Elan NanoCrystal 55 Product Characteristics 55 QLT# 55 Dementia Related Psychosis 55 Trovax 55 Act PDUFA date 55 Myfortic 55 Receives Orphan Drug Designation 55 Genzyme Myozyme 55 SNT-MC#/idebenone 55 IL# PE#QQR 55 SUCCEED trial 55 Biogen Elan 55 buccal tablets 55 liprotamase 54 Ramelteon 54 Reclast Aclasta 54 pregabalin Lyrica 54 SEROQUEL XR 54 Tarceva TM 54 NASDAQ Listing Qualification 54 FACTIVE tablets 54 Combination REOLYSIN R 54 Drug Administration FDA Endocrinologic 54 Rebif ® 54 pharmacokinetic PK study 54 Iloperidone 54 Metabasis Therapeutics 54 AVASTIN 54 FENTORA 54 Board DSMB 54 severe gastroparesis 54 Toctino ® alitretinoin 54 riociguat 54 Avanafil 54 sNDA submission 54 NV1FGF 54 Icatibant 54 Known hypersensitivity 54 Pemetrexed 54 Schizophrenia Treatment 54 Prospective Randomized 54 Phase 2a Clinical Trial 54 lasofoxifene 54 Nasdaq DVAX 54 bazedoxifene 54 prucalopride 54 Elan Tysabri 54 REBETOL combination therapy 54 Ambrisentan 54 Initiates Enrollment 54 Frovatriptan 54 Hyphanox 54 Panzem R 54 Alitretinoin 54 Silodosin 54 Sebivo 54 SILENOR 54 Benlysta belimumab 54 Onsolis 54 Approvable 54 Menaflex implant 54 Zytiga 54 BioDelivery Sciences 54 Sanvar 54 oxymorphone ER 54 Tekturna aliskiren 54 Plicera 54 AZILECT ® 54 RIGScan CR 54 Cordis Cypher 54 Revo MRI 54 Supplemental Biologics License Application 54 rilonacept 54 dalbavancin 54 DEXILANT 54 BENLYSTA ® 54 ImClone Erbitux 54 Chemophase 54 aleglitazar 54 Ticagrelor 54 Dermatologic 54 ixabepilone 54 ZOLINZA 54 HuMax EGFr 54 MoxDuo IR 54 Drug Candidate 54 ONGLYZA TM 54 Emend 54 Sitagliptin 54 pseudobulbar affect PBA 54 Pfizer Sutent 54 Voraxaze 54 Anti Clotting Drug 54 Dalbavancin 54 aripiprazole Abilify 54 Drug Eluting Stent System 54 Cholesterol Drug 54 AASLD 54 Glatiramer Acetate 54 Teriparatide 54 Blood Pressure Drug 54 Bayer Xarelto 54 MERLIN TIMI 54 oral ridaforolimus 54 Oral Calcitonin 54 ACTEMRA TM 54 Cinryze ™ 54 AZILECT R 54 ISO Vorin TM 54 LEUKINE 54 UPLYSO 54 Tracleer r 54 Biological Therapy 54 Serdolect ® 54 FIRMAGON R 54 Release Capsules 54 Zybrestat 54 Elestrin TM 54 Sparlon 54 Junovan 54 Receives Orphan Drug 54 Sunesis Pharma 54 Solesta 54 autologous cellular immunotherapy 54 InNexus Biotechnology 54 Confirmatory Phase 54 Marketing Authorization Application 54 Dificid 54 HDAC Inhibitor 54 PMPRB 54 GATTEX TM 54 vandetanib 54 Rasilez HCT 54 ORENCIA R 54 Celsion Corporation 54 Methylnaltrexone 54 Oracea TM 54 Bioequivalence 54 Stavzor 54 Kombiglyze XR 54 Alvesco R 54 granted Ortec 54 CHMP Opinion 54 Nasdaq ACHN 54 Rotavirus Vaccine 54 apricitabine ATC 54 severe hypercholesterolemia 54 Initiates Clinical Trial 54 Zingo TM 54 Mirapexin 54 SIMCOR 54 Sodium Injection 54 Receives Fast Track 54 TEMODAL 54 Pazopanib 54 Relistor 54 paliperidone palmitate 54 Tesamorelin 54 Dupuytren Contracture 54 Combidex 54 sorafenib Nexavar 54 Ceflatonin 54 Hormone Therapy 54 FDA Nonprescription Drugs 54 eprodisate Fibrillex TM 54 Phase IIb Trial 54 LEVADEX ™ 54 NGSX 54 Zavesca R 53 CLIA waived status 53 Milestone Payment From 53 Adentri 53 CHMP opinion 53 Sprycel dasatinib 53 Liprotamase 53 BYETTA ® 53 Emezine 53 CUSTOM III 53 CIP TRAMADOL ER 53 Files IND 53 #D#C# 53 Duloxetine 53 AACR NCI EORTC 53 Desvenlafaxine 53 ASBMR 53 Recommends Approval 53 Vectibix panitumumab 53 GW# [003] 53 Xyrem ® 53 Yondelis ® 53 Boxed Warning 53 Pulmonary Arterial Hypertension 53 Transcept Pharmaceuticals 53 novel oral anticoagulant 53 BLP# Liposome Vaccine 53 Survival Benefit 53 European Medicines Evaluation 53 Clevudine 53 Breaking Clinical Trials 53 Nasdaq OPTR 53 Aegerion Pharmaceuticals 53 Elvitegravir 53 Vectical TM Ointment 53 Nivestim 53 Cell Therapeutics Inc 53 Genasense ® 53 NASDAQ ARIA 53 AAMAC warrantholders 53 faropenem medoxomil 53 Roflumilast 53 KRN# 53 Zyprexa LAI 53 eltrombopag 53 carbamazepine phenobarbital phenytoin rifampin 53 Investigational Treatment 53 Femara letrozole 53 Sutent sunitinib 53 SmPC 53 HuMax CD4 53 Troxatyl 53 Keppra ® XR 53 RANK Ligand inhibitor 53 SAPHRIS 53 Gralise 53 BioSante Pharmaceuticals NASDAQ BPAX 53 Alimta pemetrexed 53 Liver Toxicity 53 Eluting Coronary Stent System 53 XIAFLEX ™ 53 EVICEL 53 Allos Therapeutics 53 Onyx Pharma 53 Complete Response Letter CRL 53 pralatrexate 53 Multaq dronedarone 53 Tekturna HCT ® 53 PREVU x LT 53 Demonstrates Significant 53 IRX 2 53 FDA Orphan Drug 53 Dabigatran etexilate 53 Postmarket 53 Pfizer maraviroc 53 NASDAQ Listing 53 midstage clinical 53 ustekinumab 53 DASISION study 53 Torisel temsirolimus 53 efalizumab 53 Augment ™ 53 ORAL Sync 53 Anadys Pharma 53 EXALGO 53 PegIntron 53 topical NSAID 53 nitrofurantoin 53 Phase III Trial 53 Cancidas 53 GTOP 53 GPhA 53 Vion Pharmaceuticals 53 Entereg 53 Investigational Drugs 53 histone deacetylase inhibitor 53 Genentech Avastin 53 phase IIb trial 53 ZIOPHARM Oncology 53 Fibrin Sealant Human 53 sipuleucel T 53 Xelox 53 Dr. Pingpank 53 Eltrombopag 53 Esbriet ® 53 Demonstrates Sustained 53 Receives Positive Opinion 53 Ziopharm 53 cetuximab Erbitux 53 Uvidem 53 Orexigen Therapeutics Inc 53 SABCS 53 Phase IIB 53 drug belatacept 53 Phase III ALLEGRO 53 Telzir 53 Transcept Pharma 53 tocilizumab 53 Orathecin 53 Onconase 53 Horizant 53 Dabigatran 53 Genzyme Synvisc 53 Announces Tentative Approval 53 Xarelto rivaroxaban 53 anidulafungin 53 FDA Panel Recommends 53 QCOR 53 Surgical Mesh 53 Cimzia R 53 Rivaroxaban 53 Ondansetron Injection USP 53 Peginterferon alfa 2b 53 Tekturna HCT 53 Plenaxis TM 53 Testosterone MDTS ® 53 Talabostat 53 Eli Lilly Cymbalta 53 Injectafer 53 oral rivaroxaban 53 Drug Approvals 53 Biosimilars 53 Biogen Idec Tysabri 53 FACTIVE R gemifloxacin 53 BioSante Pharmaceuticals 53 Cerezyme Fabrazyme Myozyme Aldurazyme 53 GRALISE 53 HCl capsules 53 Silicone Breast Implants 53 valdecoxib 53 Immunotherapeutic 53 TACI Ig 53 Quadrivalent 53 Stronger Warnings 53 Research CDER 53 NPS Pharma 53 Eucreas 53 Aztreonam 53 Azacitidine 53 Krystexxa 53 Randomized Phase 53 Surfaxin lucinactant 53 Combination Treatment 53 Brilique 53 REVLIMID R 52 Tekamlo 52 Gets FDA Clearance 52 Radiological Devices 52 Regranex 52 GARDASIL ® 52 TRO# 52 Reverset 52 markets HP Acthar 52 indiplon capsules 52 Seasonal Influenza Vaccine 52 Traficet EN 52 Viviant 52 Progenics Pharmaceuticals 52 EGRIFTA TM 52 Eszopiclone 52 TYGACIL 52 Application BLA 52 ThermoDox R 52 Frova ® 52 PANVAC VF 52 Receives Tentative FDA 52 Bayer Nexavar 52 investigational antiplatelet agent 52 PDUFA 52 YONDELIS 52 Ferumoxytol 52 Alnylam Nasdaq ALNY 52 Dr. Damaj 52 KIACTA ™ 52 Unsolicited Proposal From 52 MEVACOR 52 ACCLAIM II 52 vidofludimus 52 Avandia rosiglitazone 52 NASDAQ ISTA 52 gepirone ER 52 tramiprosate ALZHEMED TM 52 Entereg R 52 Anticancer Drug 52 Tavocept 52 UCB Cimzia 52 Zelnorm Zelmac 52 Data Suggest 52 DepoMed 52 Dr. Ayalew Tefferi 52 prGCD 52 Fluconazole 52 Premarket Approval Application 52 Naproxcinod 52 Inc. OTCBB SYBD 52 Somaxon Pharmaceuticals 52 TPSAC 52 ASGCT 52 Vaprisol 52 vildagliptin 52 NASDAQ Delisting Notice 52 AOD# [002] 52 Windhover Therapeutic Area 52 Novartis Prexige 52 NOMAC E2 52 Metastatic Melanoma 52 Hycamtin 52 Adventrx 52 Brentuximab Vedotin SGN 52 GALNS 52 Amgen Vectibix 52 Amylin Pharma 52 Acne Drug 52 Bortezomib 52 Resale Registration Statement 52 Milestone Payment 52 PRIALT 52 PRISTIQ 52 Affymax AFFY 52 Recombinant Human 52 Antisense 52 Augment Bone Graft 52 Soriatane 52 Vitrasert R 52 Nasdaq ONXX today 52 ASH Annual Meeting 52 Arranon 52 GTCbio 52 Clofarabine 52 Endocrine Society Annual Meeting 52 Seattle Genetics SGEN 52 Ixempra 52 hypersensitivity allergic reactions 52 Vaccine Diphtheria CRM# Protein 52 Teysuno 52 Premarket Approval 52 ruboxistaurin 52 Afatinib 52 NASDAQ ONXX 52 Stockholder Vote 52 Inc. Nasdaq VVUS 52 indacaterol 52 Auxilium Pharmaceuticals 52 tolerability profiles 52 agomelatine 52 Tolvaptan 52 OMAPRO ™ 52 Targretin capsules 52 Inspire Pharma 52 PTK ZK 52 OSI Tarceva 52 Teva Provides Update 52 Shire plc SHPGY 52 postmarketing surveillance 52 Dose Escalation 52 Veregen TM 52 peginesatide 52 histamine dihydrochloride 52 panitumumab Vectibix 52 antiplatelet agent 52 BLA submission 52 Aztreonam Lysine 52 Nasdaq VRTX today 52 Exalgo 52 PLAVIX ® 52 CYTR 52 OvaRex MAb 52 EMBEDA ™ 52 MELA Sciences 52 Nuvion 52 bifeprunox 52 Tredaptive 52 Thalidomide Pharmion 52 pioglitazone Actos 52 CPMP 52 Oracea ® 52 Propoxyphene 52 Ereska 52 ongoing Phase 1b 52 NCCN Guidelines Panel 52 NASDAQ CLSN 52 BiDil XR 52 NYSE Amex HEB 52 Electro Optical Sciences 52 Afresa 52 Adjunctive Therapy 52 vapreotide acetate 52 Afinitor ® 52 CERVARIX 52 DCCR 52 Hsp# Inhibitor 52 Nasdaq SLXP 52 clevidipine 52 Dr. McHutchison 52 Protalix BioTherapeutics PLX 52 Anika Therapeutics 52 Intuniv 52 Aptivus ® 52 PEG SN# 52 OLEPTRO 52 ISENTRESS 52 NASDAQ Listing Requirements 52 Eurand NV EURX 52 Drug Administration FDA 52 Milnacipran 52 Uterine Cancer 52 Besivance 52 recombinant thrombin 52 Nasdaq MNKD 52 Marketing Authorisation Application MAA 52 Selective Serotonin Reuptake Inhibitor 52 Aspreva 52 Saphris 52 Novartis AG Galvus 52 XGEVA ™ 52 Gamunex C 52 Voraxaze ™ 52 Premarket Approval PMA 52 SUSTENNA TM 52 Montelukast 52 virus HCV protease inhibitor 52 SUPPRELIN R LA 52 methylnaltrexone bromide 52 Elocalcitol 52 Nesiritide 52 Adenuric R 52 Combating Counterfeit Drugs 52 vemurafenib 52 aldosterone antagonists 52 asymptomatic hyperuricemia 52 Inc. Nasdaq MLNM 52 Drug Coated Stent 52 CNTO 52 MELA Sciences Inc. 52 pertuzumab 52 Erectile Dysfunction Drug 52 Xolegel 52 Penwest Pharmaceuticals Co. 52 Denosumab 52 Inc. Nasdaq IMGN 52 Synvisc One 52 interferon gamma 1b 52 TORISEL 52 Adventrx Pharmaceuticals 52 Fludara ® 52 Wyeth Progenics 52 orphan designation 52 ImmunoCellular Therapeutics 52 Deforolimus 52 Rotavirus Vaccines 52 NASDAQ TRBN 52 Committee IDMC 52 OHRP 52 Investigational Agent 52 Safinamide 52 INVIRASE 52 Romidepsin 52 First Patient Treated 52 Savient Pharmaceuticals 52 Mylan Receives Approval 52 azficel T 52 Employment Inducement Awards 52 Provenge Dendreon 52 Somatuline Depot 52 Intelence 52 sunitinib Sutent 52 Revlimid lenalidomide 52 ENDEAVOR III 52 Inc. OTCBB VODG 52 Avanir 52 Mg Usa 52 Allovectin 7 ® 52 ASCEND HF 52 YONDELIS R 52 Simulect 52 Esbriet pirfenidone 52 Single Dose 52 Nasdaq NBIX 52 CRME 52 Antiviral Activity 52 BioMarin Pharma 52 Everolimus 52 INAMED 52 Low Dose 52 Dacogen injection 52 Focalin XR R 52 OvaDx 52 PMA submission 52 Troxatyl TM 52 Ceflatonin ® 51 Motavizumab 51 FDA APPROVES 51 Elan Biogen 51 LymphoStat B TM 51 Sunesis Pharmaceuticals 51 R roscovitine 51 Entocort 51 Idenix Pharma 51 Nasdaq CTIC 51 Mepact 51 Nasdaq ADLR 51 Nasdaq MGRM 51 Randomized Controlled Trials 51 Perforomist ™ Inhalation Solution 51 Trandolapril 51 GlaxoSmithKline Plc diabetes 51 Cyclacel Pharmaceuticals 51 Zelapar 51 ACCORD Lipid 51 NitroMist TM 51 octreotide acetate 51 Natroba 51 IMPACT IMmunotherapy 51 ponatinib 51 Pentacel vaccine 51 BrachySil 51 Therapeutic Potential 51 OsmoPrep 51 Receive Milestone Payment 51 Cubist Pharma 51 QNEXA ® 51 casopitant 51 anakinra 51 Rosiglitazone 51 Subpart H 51 sapropterin dihydrochloride 51 Dyloject TM 51 MelaFind R 51 Extended Release 51 Panitumumab 51 Zemplar 51 Eribulin 51 OGXI 51 Annual ICAAC 51 WILEX 51 CTAP# Capsules 51 Amylin AMLN 51 Accelerated Assessment 51 LUVENIQ 51 Denufosol 51 Canaccord Adams Hepatitis C 51 Focetria 51 elotuzumab 51 Qutenza TM 51 Topiramate 51 NCCN Drugs 51 vismodegib 51 ENZN 51 Tablets #mg [001] 51 Investigational Device Exemption 51 Lu AA# 51 SIR Spheres 51 Qnexa 51 HoFH 51 Roche Herceptin 51 RoACTEMRA 51 Diamyd r 51 ATHX 51 Protalix BioTherapeutics 51 Spirus Medical 51 orphan medicinal product 51 ACIP 51 Generic Version Of 51 LY# [003] 51 pan HDAC inhibitor 51 mesylate 51 Zensana 51 Bevacizumab 51 Intermezzo ® NDA 51 atypical antipsychotic medication 51 Vioxx Successor 51 Gestiva ™ 51 Uloric 51 FUSILEV ® 51 Amex ANX 51 sitaxsentan sodium 51 Velaglucerase Alfa 51 ONSOLIS 51 Nuedexta 51 European Medicines Agency 51 Milestone Payments 51 ATryn 51 Fibrillex TM 51 Clinical Trials Update 51 Biosante 51 VALSTAR 51 Retacrit 51 oral anticoagulant 51 IsoTis stockholders 51 ANTEGREN 51 Clinical Guideline 51 Javelin Pharmaceuticals 51 Canvaxin 51 phase Ib 51 methylnaltrexone 51 Zelrix 51 Nasdaq IMGN 51 Second Pivotal Phase 51 MDCO 51 SPRYCEL ® 51 oral FTY# 51 Neurodex 51 Feraheme ® 51 OSMOPREP TM 51 Antibody Therapeutics 51 Neoadjuvant 51 NIH Consensus